The STI CRC Administrative Core will provide strong scientific and administrative leadership and highly effective support to all CRC components to enable the CRC to fully accomplish its goals. The Administrative Core will coordinate, supervise, and efficiently and expertly manage all CRC activities to create a cohesive and integrated program;facilitate communication and collaborative activities within the CRC and with all CRCs, the STI community, and NIAID staff;manage the reporting process;ensure fiscal and regulatory compliance;and foster research careers of new investigators in STI research.
Our first Aim i s to conduct efficient, effective, timely, and collegial management of the STI CRC's operations; which will be accomplished by strategic planning to manage and implement CRC activities;fostering a collaborative environment to keep pace with emerging needs, opportunities, and scientific priorities;and efficiently managing the CRC budget and perform all fiscal, grant, personnel, and compliance functions for the CRC, and support Research Project and Core functions.
Our second Aim i s to attract, train and retain promising new investigators to STI research and promote their career development to ensure a continued pipeline of high-quality investigators in the STI research field;which we will accomplish by recruiting and retaining talented new investigators from a variety of disciplines into the field of STI research, and providing research support and mentoring to STI-CRC developmental awardees at a critical point in their career development. The UW has been a center for innovative and important work on STI/HIV for nearly 40 years, and is an ideal place for this STI CRC. Historically, faculty and former trainees of this program have made fundamental contributions to understanding and controlling these diseases. The STI CRC Administrative Core will be co-located with related STI/HIV research and training programs including the STD/AIDS Research Training Program, the UW Center for AIDS Research, and the UW Center for AIDS and STD, among many others, providing a strong and synergistic base of operations for this Core.
|Khosropour, Christine M; Dombrowski, Julia C (2018) A Web of Complexity: Untangling the Routes of Rectal Chlamydia Acquisition. Sex Transm Dis 45:511-513|
|Fink, Susan L; Vojtech, Lucia; Wagoner, Jessica et al. (2018) The Antiviral Drug Arbidol Inhibits Zika Virus. Sci Rep 8:8989|
|Reeves, Daniel B; Duke, Elizabeth R; Wagner, Thor A et al. (2018) A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation. Nat Commun 9:4811|
|Khosropour, Christine M; Bell, Teal R; Hughes, James P et al. (2018) A Population-Based Study to Compare Treatment Outcomes Among Women With Urogenital Chlamydial Infection in Washington State, 1992 to 2015. Sex Transm Dis 45:319-324|
|Balle, Christina; Lennard, Katie; Dabee, Smritee et al. (2018) Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection. Sci Rep 8:11109|
|Gasper, Melanie A; Hesseling, Anneke C; Mohar, Isaac et al. (2017) BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial. JCI Insight 2:e91963|
|Manhart, Lisa E (2017) Mycoplasma genitalium on the Loose: Time to Sound the Alarm. Sex Transm Dis 44:463-465|
|Herbst-Kralovetz, Melissa M; Pyles, Richard B; Ratner, Adam J et al. (2016) New Systems for Studying Intercellular Interactions in Bacterial Vaginosis. J Infect Dis 214 Suppl 1:S6-S13|
|Gasper, Melanie A; Biswas, Shameek P; Fisher, Bridget S et al. (2016) Nonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCG. PLoS One 11:e0158149|
|Mayer, Bryan T; Srinivasan, Sujatha; Fiedler, Tina L et al. (2015) Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. J Infect Dis 212:793-802|
Showing the most recent 10 out of 12 publications